[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
IJRR Information::
For Authors::
For Reviewers::
Subscription::
News & Events::
Web Mail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
ISSN
Hard Copy 2322-3243
Online 2345-4229
..
Online Submission
Now you can send your articles to IJRR office using the article submission system.
..

AWT IMAGE

AWT IMAGE

:: Volume 23, Issue 4 (10-2025) ::
Int J Radiat Res 2025, 23(4): 1091-1099 Back to browse issues page
Disease Burden of Gynecological Tumors and radiotherapy effectiveness: A Systematic Review based on Epidemiological Insights
X. Zhang , J. Liu , Y. Fu
Abstract:   (36 Views)
Background: Gynecological cancers-including cervical, ovarian, endometrial, vulvar, vaginal, and gestational trophoblastic neoplasms-pose significant global health challenges, particularly in low- and middle-income countries (LMICs). Radiotherapy is a cornerstone of treatment, yet access remains limited in under-resourced regions, contributing to poor outcomes. This systematic review investigates the epidemiology and disease burden of gynecological cancers, focusing on incidence trends, risk factors, geographical variation, histopathological subtypes, and tumor mutational burden (TMB). It also evaluates the effectiveness of radiotherapy and the potential of personalized approaches guided by molecular profiling. Materials and Methods: A systematic search following PRISMA guidelines was conducted across PubMed, Scopus, Web of Science, and Embase for studies published between 2000 and 2023. Study quality was assessed using the QUADAS-2 tool. Results: Nine studies met the inclusion criteria. Cervical cancer showed the highest incidence, with increasing trends in some regions. High TMB was associated with aggressive histological subtypes and poorer survival, highlighting its value as a predictive biomarker. Radiotherapy significantly improved outcomes, especially when integrated into personalized treatment plans based on molecular characteristics. Conclusion: The global burden of gynecological cancers is rising, with substantial disparities in diagnosis and treatment access, especially in LMICs. Radiotherapy remains vital, but outcomes may be further improved through TMB-guided personalization. Expanding radiotherapy infrastructure and integrating molecular diagnostics are crucial for addressing global inequities and enhancing treatment efficacy.
Keywords: Gynecologic neoplasms, radiotherapy, tumor mutational burden, precision medicine, uterine cervical neoplasms.
Full-Text [PDF 1205 kb]   (13 Downloads)    
Type of Study: Review article | Subject: Radiation Biology
Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zhang X, Liu J, Fu Y. Disease Burden of Gynecological Tumors and radiotherapy effectiveness: A Systematic Review based on Epidemiological Insights. Int J Radiat Res 2025; 23 (4) :1091-1099
URL: http://ijrr.com/article-1-6820-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 23, Issue 4 (10-2025) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 48 queries by YEKTAWEB 4735